Distinct immunomodulatory and migratory mechanisms underpin the therapeutic potential of human mesenchymal stem cells in autoimmune demyelination

Cell Transplantation

Volumn 22, Issue 8, 2013, Pages 1409-1425

  Payne, Natalie L ^a   Sun, Guizhi ^a   Mcdonald, Courtney ^a   Layton, Daniel ^a   Moussa, Leon ^a   Emerson Webber, Ashley ^a   Veron, Nadege ^a   Siatskas, Christopher ^a   Herszfeld, Daniella ^a   Price, John ^a   Bernard, Claude C A ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Cell migration; Experimental autoimmune encephalomyelitis (EAE); Immunomodulation; Mesenchymal stem cells (MSCs); Multiple sclerosis (MS)

Indexed keywords

CYTOKINE; MITOGENIC AGENT;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CELL ISOLATION; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE COURSE; EXPERIMENTAL MODEL; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; OUTCOME ASSESSMENT; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; TISSUE REPAIR;

ADIPOSE TISSUE; ANIMALS; AUTOANTIGENS; BONE MARROW CELLS; CELL MOVEMENT; CELL PROLIFERATION; CHRONIC DISEASE; CYTOKINES; DISEASE PROGRESSION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HUMANS; IMMUNOMODULATION; IMMUNOPHENOTYPING; INTERFERON-GAMMA; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; ORGAN SPECIFICITY; RECEPTORS, CHEMOKINE; RNA, MESSENGER; SOLUBILITY; SPLEEN; T-LYMPHOCYTES; TREATMENT OUTCOME; UMBILICAL CORD;

EID: 84880996557     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368912X657620     Document Type: Article

References (76)

1. Augello, A.; Tasso, R.; Negrini, S. M.; Cancedda, R.; Pennesi, G. Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collageninduced arthritis. Arthritis Rheum. 56(4):1175-1186; 2007.
2. Bai, L.; Lennon, D. P.; Caplan, A. I.; DeChant, A.; Hecker, J.; Kranso, J.; Zaremba, A.; Miller, R. H. Hepatocyte growth factor mediates mesenchymal stem cell-induced recovery in multiple sclerosis models. Nat. Neurosci. 15(6):868-870; 2012.
3. Bai, L.; Lennon, D. P.; Eaton, V.; Maier, K.; Caplan, A. I.; Miller, S. D.; Miller, R. H. Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis. Glia 57(11):1192-1203; 2009.
4. Balasubramanian, S.; Venugopal, P.; Sundarraj, S.; Zakaria, Z.; Majumdar, A. S.; Ta, M. Comparison of chemokine and receptor gene expression between Wharton's jelly and bone marrow-derived mesenchymal stromal cells. Cytotherapy 14(1):26-33; 2012.
5. Barr, T. A.; Shen, P.; Brown, S.; Lampropoulou, V.; Roch, T.; Lawrie, S.; Fan, B.; O'Connor, R. A.; Anderton, S. M.; Bar-Or, A.; Fillatreau, S.; Gray, D. B-cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B-cells. J. Exp. Med. 209(5):1001-1010; 2012.
6. Bettadapura, J.; Menon, K. K.; Moritz, S.; Liu, J.; Bernard, C. C,Expression purification, and encephalitogenicity of recombinant human myelin oligodendrocyte glycoprotein. J. Neurochem. 70(4):1593-1599; 1998.
7. Bettelli, E.; Pagany, M.; Weiner, H. L.; Linington, C.; Sobel, R. A.; Kuchroo, V. K. Myelin oligodendrocyte glycoproteinspecific T-cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J. Exp. Med. 197(9): 1073-1081; 2003.
8. Beyth, S.; Borovsky, Z.; Mevorach, D.; Liebergall, M.; Gazit, Z.; Aslan, H.; Galun, E.; Rachmilewitz, J. Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood 105(5): 2214-2219; 2005.
9. Bochev, I.; Elmadjian, G.; Kyurkchiev, D.; Tzvetanov, L.; Altankova, I.; Tivchev, P.; Kyurkchiev, S. Mesenchymal stem cells from human bone marrow or adipose tissue differently modulate mitogen-stimulated B-cell immunoglobulin production in vitro. Cell Biol. Int. 32(4):384-393; 2008.
10. Brooke, G.; Tong, H.; Levesque, J. P.; Atkinson, K. Molecular trafficking mechanisms of multipotent mesenchymal stem cells derived from human bone marrow and placenta. Stem Cells Dev. 17(5):929-940; 2008.
11. Chang, J. W.; Hung, S. P.; Wu, H. H.; Wu, W. M.; Yang, A. H.; Tsai, H. L.; Yang, L. Y.; Lee, O. K. Therapeutic effects of umbilical cord blood-derived mesenchymal stem cell transplantation in experimental lupus nephritis. Cell Transplant. 20(2):245-257; 2011.
12. Coisne, C.; Mao, W.; Engelhardt, B. Cutting edge: Natalizumab blocks adhesion but not initial contact of human T-cells to the blood-brain barrier in vivo in an animal model of multiple sclerosis. J. Immunol. 182(10):5909-5913; 2009.
13. Constantin, G. Chemokine signaling and integrin activation in lymphocyte migration into the inflamed brain. J. Neuroimmunol. 198(1-2):20-26; 2008.
14. Constantin, G.; Marconi, S.; Rossi, B.; Angiari, S.; Calderan, L.; Anghileri, E.; Gini, B.; Bach, S. D.; Martinello, M.; Bifari, F.; Galie, M.; Turano, E.; Budui, S.; Sbarbati, A.; Krampera, M.; Bonetti, B. Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis. Stem Cells 27(10):2624-2635; 2009.
15. Corcione, A.; Benvenuto, F.; Ferretti, E.; Giunti, D.; Cappiello, V.; Cazzanti, F.; Risso, M.; Gualandi, F.; Mancardi, G. L.; Pistoia, V.; Uccelli, A. Human mesenchymal stem cells modulate B-cell functions. Blood 107(1): 367-372; 2006.
16. Crisan, M.; Yap, S.; Casteilla, L.; Chen, C. W.; Corselli, M.; Park, T. S.; Andriolo, G.; Sun, B.; Zheng, B.; Zhang, L.; Norotte, C.; Teng, P. N.; Traas, J.; Schugar, R.; Deasy, B. M.; Badylak, S.; Buhring, H. J.; Giacobino, J. P.; Lazzari, L.; Huard, J.; Peault, B. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3(3):301-313; 2008.
17. Croitoru-Lamoury, J.; Lamoury, F. M.; Zaunders, J. J.; Veas, L. A.; Brew, B. J. Human mesenchymal stem cells constitutively express chemokines and chemokine receptors: that can be upregulated by cytokines, IFN-b, and copaxone. J. Interferon Cytokine Res. 27(1):53-64; 2007.
18. Da Silva Meirelles, L.; Chagastelles, P. C.; Nardi, N. B. Mesenchymal stem cells reside in virtually all postnatal organs and tissues. J. Cell Sci. 119(Pt 11):2204-2213; 2006.
19. De Grendele, H. C.; Estess, P.; Siegelman, M. H. Requirement for CD44 in activated T-cell extravasation into an inflammatory site. Science 278(5338):672-675; 1997.
20. De Ugarte, D. A.; Alfonso, Z.; Zuk, P. A.; Elbarbary, A.; Zhu, M.; Ashjian, P.; Benhaim, P.; Hedrick, M. H.; Fraser, J. K. Differential expression of stem cell mobilization-associated molecules on multi-lineage cells from adipose tissue and bone marrow. Immunol. Lett. 89(2-3):267-270; 2003.
21. Di Ianni, M.; Del Papa, B.; De Ioanni, M.; Moretti, L.; Bonifacio, E.; Cecchini, D.; Sportoletti, P.; Falzetti, F.; Tabilio, A. Mesenchymal cells recruit and regulate T regulatory cells. Exp. Hematol. 36(3):309-318; 2008.
22. Di Nicola, M.; Carlo-Stella, C.; Magni, M.; Milanesi, M.; Longoni, P. D.; Matteucci, P.; Grisanti, S.; Gianni, A. M. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99(10):3838-3843; 2002.
23. Dominici, M.; Le Blanc, K.; Mueller, I.; Slaper-Cortenbach, I.; Marini, F.; Krause, D.; Deans, R.; Keating, A.; Prockop, D.; Horwitz, E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8(4): 315-317; 2006.
24. Dutta, R.; Trapp, B. D. Pathogenesis of axonal and neuronal damage in multiple sclerosis. Neurology 68(22 suppl 3): S22-S31; 2007.
25. Fillatreau, S.; Gray, D.; Anderton, S. M. Not always the bad guys: B-cells as regulators of autoimmune pathology. Nat. Rev. Immunol. 8(5):391-397; 2008.
26. Fiorina, P.; Jurewicz, M.; Augello, A.; Vergani, A.; Dada, S.; La Rosa, S.; Selig, M.; Godwin, J.; Law, K.; Placidi, C.; Smith, R. N.; Capella, C.; Rodig, S.; Adra, C. N.; Atkinson, M.; Sayegh, M. H.; Abdi, R. Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes. J. Immunol. 183(2):993-1004; 2009.
27. Fischer, U. M.; Harting, M. T.; Jimenez, F.; Monzon- Posadas, W. O.; Xue, H.; Savitz, S. I.; Laine, G. A.; Cox, Jr,C. S. Pulmonary passage is a major obstacle for intravenous stem cell delivery: The pulmonary first-pass effect, Stem Cells Dev. 18(5):683-692; 2009.
28. Gao, H.; Priebe, W.; Glod, J.; Banerjee, D. Activation of signal transducers and activators of transcription 3 and focal adhesion kinase by stromal cell-derived factor 1 is required for migration of human mesenchymal stem cells in response to tumor cell-conditioned medium. Stem Cells 27(4):857-865; 2009.
29. Gerdoni, E.; Gallo, B.; Casazza, S.; Musio, S.; Bonanni, I.; Pedemonte, E.; Mantegazza, R.; Frassoni, F.; Mancardi, G.; Pedotti, R.; Uccelli, A. Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis. Ann. Neurol. 61(3):219-227; 2007.
30. Goodwin, M.; Sueblinvong, V.; Eisenhauer, P.; Ziats, N. P.; LeClair, L.; Poynter, M. E.; Steele, C.; Rincon, M.; Weiss, D. J. Bone marrow-derived mesenchymal stromal cells inhibit Th2-mediated allergic airways inflammation in mice. Stem Cells 29(7):1137-1148; 2011.
31. Gordon, D.; Pavlovska, G.; Glover, C. P.; Uney, J. B.; Wraith, D.; Scolding, N. J. Human mesenchymal stem cells abrogate experimental allergic encephalomyelitis after intraperitoneal injection, and with sparse CNS infiltration. Neurosci. Lett. 448(1):71-73; 2008.
32. Gordon, D.; Pavlovska, G.; Uney, J. B.; Wraith, D. C.; Scolding, N. J. Human mesenchymal stem cells infiltrate the spinal cord, reduce demyelination, and localize to white matter lesions in experimental autoimmune encephalomyelitis. J. Neuropathol. Exp. Neurol. 69(11):1087-1095; 2010.
33. Gur-Wahnon, D.; Borovsky, Z.; Beyth, S.; Liebergall, M.; Rachmilewitz, J. Contact-dependent induction of regulatory antigen-presenting cells by human mesenchymal stem cells is mediated via STAT3 signaling. Exp. Hematol. 35(3):426-433; 2007.
34. Hemeda, H.; Jakob, M.; Ludwig, A. K.; Giebel, B.; Lang, S.; Brandau, S. Interferon-g and tumor necrosis factor-a differentially affect cytokine expression and migration properties of mesenchymal stem cells. Stem Cells Dev. 19(5):693-706; 2010.
35. Holman, D. W.; Klein, R. S.; Ransohoff, R. M. The blood- brain barrier, chemokines and multiple sclerosis. Biochim. Biophys. Acta 1812(2):220-230; 2012.
36. Honczarenko, M.; Le, Y.; Swierkowski, M.; Ghiran, I.; Glodek, A. M.; Silberstein, L. E. Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors. Stem Cells 24(4):1030-1041; 2006.
37. Ivanova-Todorova, E.; Bochev, I.; Mourdjeva, M.; Dimitrov, R.; Bukarev, D.; Kyurkchiev, S.; Tivchev, P.; Altunkova, I.; Kyurkchiev, D. S. Adipose tissue-derived mesenchymal stem cells are more potent suppressors of dendritic cells differentiation compared to bone marrowderived mesenchymal stem cells. Immunol. Lett. 126(1-2): 37-42; 2009.
38. Karp, J. M.; Leng Teo, G. S. Mesenchymal stem cell homing: The devil is in the details. Cell Stem Cell 4(3):206-216; 2009.
39. Kassis, I.; Grigoriadis, N.; Gowda-Kurkalli, B.; Mizrachi- Kol, R.; Ben-Hur, T.; Slavin, S.; Abramsky, O.; Karussis, D. Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis. Arch. Neurol. 65(6):753-761; 2008.
40. Kern, S.; Eichler, H.; Stoeve, J.; Kluter, H.; Bieback, K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 24(5):1294-1301; 2006.
41. Kieseier, B. C.; Wiendl, H.; Leussink, V. I.; Stuve, O. Immunomodulatory treatment strategies in multiple sclerosis. J. Neurol. 255(Suppl 6):15-21; 2008.
42. Krampera, M. Mesenchymal stromal cell 'licensing': A multistep process. Leukemia 25(9):1408-1414; 2011.
43. Krampera, M.; Glennie, S.; Dyson, J.; Scott, D.; Laylor, R.; Simpson, E.; Dazzi, F. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigenspecific T-cells to their cognate peptide. Blood 101(9): 3722-3729; 2003.
44. Kumar, S.; Ponnazhagan, S. Bone homing of mesenchymal stem cells by ectopic {alpha}4 integrin expression. FASEB J. 21(14):3917-3927; 2007.
45. Lai, C. F.; Ripperger, J.; Morella, K. K.; Jurlander, J.; Hawley, T. S.; Carson, W. E.; Kordula, T.; Caligiuri, M. A.; Hawley, R. G.; Fey, G. H.; Baumann, H. Receptors for interleukin (IL)-10 and IL-6-type cytokines use similar signaling mecha-nisms for inducing transcription through IL-6 response elements. J. Biol. Chem. 271(24):13968-13975; 1996.
46. Lanza, C.; Morando, S.; Voci, A.; Canesi, L.; Principato, M. C.; Serpero, L. D.; Mancardi, G.; Uccelli, A.; Vergani, L. Neuroprotective mesenchymal stem cells are endowed with a potent antioxidant effect in vivo. J. Neurochem. 110(5):1674-1684; 2009.
47. Lee, R. H.; Pulin, A. A.; Seo, M. J.; Kota, D. J.; Ylostalo, J.; Larson, B. L.; Semprun-Prieto, L.; Delafontaine, P.; Prockop, D. J. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 5(1):54-63; 2009.
48. Liu, J.; Marino, M. W.; Wong, G.; Grail, D.; Dunn, A.; Bettadapura, J.; Slavin, A. J.; Old, L.; Bernard, C. C. TNF is a potent anti-inflammatory cytokine in autoimmunemediated demyelination. Nat. Med. 4(1):78-83; 1998.
49. Lundberg, J.; Sodersten, E.; Sundstrom, E.; Le Blanc, K.; Andersson, T.; Hermanson, O.; Holmin, S. Targeted intra-arterial transplantation of stem cells to the injured CNS is more effective than intravenous administration: Engraftment is dependent on cell type and adhesion molecule expression. Cell Transplant. 21(1):333-343; 2012.
50. Lyons, J. A.; Ramsbottom, M. J.; Cross, A. H. Critical role of antigen-specific antibody in experimental autoimmune encephalomyelitis induced by recombinant myelin oligodendrocyte glycoprotein. Eur. J. Immunol. 32(7):1905-1913; 2002.
51. Matozaki, T.; Murata, Y.; Okazawa, H.; Ohnishi, H. Functions and molecular mechanisms of the CD47-SIRPa signalling pathway. Trends Cell Biol. 19(2):72-80; 2009.
52. McQualter, J. L.; Bernard, C. C. Multiple sclerosis: A battle between destruction and repair. J. Neurochem. 100(2):295-306; 2007.
53. McQualter, J. L.; Darwiche, R.; Ewing, C.; Onuki, M.; Kay, T. W.; Hamilton, J. A.; Reid, H. H.; Bernard, C. C. Granulocyte macrophage colony-stimulating factor: A new putative therapeutic target in multiple sclerosis. J. Exp. Med. 194(7):873-882; 2001.
54. Mendez-Ferrer, S.; Michurina, T. V.; Ferraro, F.; Mazloom, A. R.; Macarthur, B. D.; Lira, S. A.; Scadden, D. T.; Ma'ayan, A.; Enikolopov, G. N.; Frenette, P. S. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 466(7308):829-834; 2010.
55. Noel, D.; Caton, D.; Roche, S.; Bony, C.; Lehmann, S.; Casteilla, L.; Jorgensen, C.; Cousin, B. Cell specific differences between human adipose-derived and mesenchymal-stromal cells despite similar differentiation potentials. Exp. Cell Res. 314(7):1575-1584; 2008.
56. Payne, N. L.; Sun, G.; Herszfeld, D.; Tat-Goh, P. A.; Verma, P. J.; Parkington, H. C.; Coleman, H. A.; Tonta, M. A.; Siatskas, C.; Bernard, C. C. Comparative study on the therapeutic potential of neurally differentiated stem cells in a mouse model of multiple sclerosis. PLoS One 7(4):e35093; 2012.
57. Petermann, F.; Korn, T. Cytokines and effector T-cell subsets causing autoimmune CNS disease. FEBS Lett. 585(23):3747-3757; 2011.
58. Pittenger, M. F.; Mackay, A. M.; Beck, S. C.; Jaiswal, R. K.; Douglas, R.; Mosca, J. D.; Moorman, M. A.; Simonetti, D. W.; Craig, S.; Marshak, D. R. Multilineage potential of adult human mesenchymal stem cells. Science 284(5411):143-147; 1999.
59. Pluchino, S.; Zanotti, L.; Rossi, B.; Brambilla, E.; Ottoboni, L.; Salani, G.; Martinello, M.; Cattalini, A.; Bergami, A.; Furlan, R.; Comi, G.; Constantin, G.; Martino, G. Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism. Nature 436(7048):266-271; 2005.
60. Prasanna, S. J.; Gopalakrishnan, D.; Shankar, S. R.; Vasandan, A. B. Pro-inflammatory cytokines, IFN-g and TNF-a, influence immune properties of human bone marrow and Wharton jelly mesenchymal stem cells differentially. PLoS One 5(2):e9016; 2010.
61. Rafei, M.; Birman, E.; Forner, K.; Galipeau, J. Allogeneic mesenchymal stem cells for treatment of experimental autoimmune encephalomyelitis. Mol. Ther. 17(10):1799-1803; 2009.
62. Rafei, M.; Campeau, P. M.; Aguilar-Mahecha, A.; Buchanan, M.; Williams, P.; Birman, E.; Yuan, S.; Young, Y. K.; Boivin, M. N.; Forner, K.; Basik, M.; Galipeau, J. Mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by inhibiting CD4 Th17 T-cells in a CC chemokine ligand 2-dependent manner. J. Immunol. 182(10):5994-6002; 2009.
63. Rasmusson, I.; Uhlin, M.; Le Blanc, K.; Levitsky, V. Mesenchymal stem cells fail to trigger effector functions of cytotoxic T-lymphocytes. J. Leukoc. Biol. 82(4):887-893; 2007.
64. Rossi, B.; Angiari, S.; Zenaro, E.; Budui, S. L.; Constantin, G. Vascular inflammation in central nervous system diseases: Adhesion receptors controlling leukocyte-endothelial interactions. J. Leukoc. Biol. 89(4):539-556; 2011.
65. Sajic, M.; Hunt, D. P.; Lee, W.; Compston, D. A.; Schweimer, J. V.; Gregson, N. A.; Chandran, S.; Smith, K. J. Mesenchymal stem cells lack efficacy in the treatment of experimental autoimmune neuritis despite in vitro inhibition of T-cell proliferation. PLoS One 7(2):e30708; 2012.
66. Schurgers, E.; Kelchtermans, H.; Mitera, T.; Geboes, L.; Matthys, P. Discrepancy between the in vitro and in vivo effects of murine mesenchymal stem cells on T-cell proliferation and collagen-induced arthritis Arthritis. Res. Ther. 12(1):R31; 2010.
67. Siatskas, C.; Seach, N.; Sun, G.; Emerson-Webber, A.; Silvain, A.; Toh, B. H.; Alderuccio, F.; Backstrom, B. T.; Boyd, R. L.; Bernard, C. C. Thymic Gene Transfer of Myelin Oligodendrocyte Glycoprotein Ameliorates the Onset but Not the Progression of Autoimmune Demyelination. Mol. Ther. 20:1349-1359; 2012.
68. Singer, N. G.; Caplan, A. I. Mesenchymal stem cells: Mechanisms of inflammation. Annu. Rev. Pathol. 6:457-478; 2011.
69. Sudres, M.; Norol, F.; Trenado, A.; Gregoire, S.; Charlotte, F.; Levacher, B.; Lataillade, J.-J.; Bourin, P.; Holy, X.; Vernant, J.-P.; Klatzmann, D.; Cohen, J. L. Bone marrow mesenchymal stem cells suppress lymphocyte proliferation in vitro but fail to prevent graft-versus-host disease in mice. J. Immunol. 176(12):7761-7767; 2006.
70. Tondreau, T.; Meuleman, N.; Stamatopoulos, B.; De Bruyn, C.; Delforge, A.; Dejeneffe, M.; Martiat, P.; Bron, D.; Lagneaux, L. In vitro study of matrix metalloproteinase/ tissue inhibitor of metalloproteinase production by mesenchymal stromal cells in response to inflammatory cytokines: The role of their migration in injured tissues. Cytotherapy 11(5):559-569; 2009.
71. Tse, W. T.; Pendleton, J. D.; Beyer, W. M.; Egalka, M. C.; Guinan, E. C. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: Implications in transplantation. Transplantation 75(3):389-397; 2003.
72. Uccelli, A.; Prockop, D. J. Why should mesenchymal stem cells (MSCs) cure autoimmune diseases? Curr. Opin. Immunol. 22(6):768-774; 2010.
73. Weber, M. S.; Prod'homme, T.; Patarroyo, J. C.; Molnarfi, N.; Karnezis, T.; Lehmann-Horn, K.; Danilenko, D. M.; Eastham-Anderson, J.; Slavin, A. J.; Linington, C.; Bernard, C. C.; Martin, F.; Zamvil, S. S.B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity. Ann. Neurol. 68(3):369-383; 2010.
74. Wilson, A.; Trumpp, A. Bone-marrow haematopoieticstem-cell niches. Nat. Rev. Immunol. 6(2):93-106; 2006.
75. Zappia, E.; Casazza, S.; Pedemonte, E.; Benvenuto, F.; Bonanni, I.; Gerdoni, E.; Giunti, D.; Ceravolo, A.; Cazzanti, F.; Frassoni, F.; Mancardi, G.; Uccelli, A. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 106(5):1755-1761; 2005.
76. Zhu, H.; Mitsuhashi, N.; Klein, A.; Barsky, L. W.; Weinberg, K.; Barr, M. L.; Demetriou, A.; Wu, G. D. The role of the hyaluronan receptor CD44 in mesenchymal stem cell migration in the extracellular matrix. Stem Cells 24(4):928-935; 2006.